BioSpace News Archive

Amarin Corporation plc (NASDAQ:AMRN) today provided an update following the decision by the U.S. Court of Appeals for the Federal Circuit in the company’s ongoing patent litigation. The Court upheld the March ruling by the U.S. District Court for the District of Nevada in favor of two generic companies in connection with their abbreviated new drug applications, or ANDAs, related to Amarin’s VASCEPA® (icosapent ethyl) cap

Emerald Bioscience, Inc. (OTCQB: EMBI a preclinical-stage biopharmaceutical company focused on the development of proprietary first-in-class molecules with strong clinical and commercial differentiation, announced today that Punit Dhillon, CEO, Emerald Bioscience will present a corporate overview at the H.C. Wainwright 22nd Annual Global Investment Conference on Tuesday, September 15, 2020. Mr. Dhillon will also be available for virtual one-o

Kriya Therapeutics , a next generation gene therapy company focused on developing transformative treatments for highly prevalent diseases, announced today that its CEO, Shankar Ramaswamy, M.D., will present at multiple upcoming healthcare conferences in September and October. These includ

Cerebain Biotech Corp., previously announced, on August 25, 2020, that it had entered into a Letter of Intent to purchase the assets of PKG, Inc..

Gold standard clinical practice guidelines in oncology updated and translated for greater global accessibility; free online at NCCN.org/global.

Neogen Corporation (NASDAQ: NEOG) announced today that it has entered into a sponsorship agreement with the National FFA that will support the agricultural organization and help fight the spread of COVID-19. Under terms of the agreement, Neogen will donate $1 to the National FFA for every 7 ounce bottle of COMPANION™ Hand S

Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, announced that company management will be presenting at the following virtual investor conferences:

MediWound Ltd. (Nasdaq: MDWD) (the “Company”), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that Sharon Malka, MediWound’s Chief Executive Officer, will present at the following investor conferences in September: 2020 Wells Fargo Virtual Healthcare Conference Date: September 10, 2020 Time: 8:40am ET Format: Virtual Presentation H.C. W

Advanced Therapies & Expo 2020 on September 9 CIRM 2020 Grantee Meeting on September 14 Collaborations That Transform MS Webinar on September 24 NEW YORK, Sept. 03, 2020 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced that it will deliver virtual presentations during Advanced Therapies & Expo 2020, September 9, at the 2020 CIRM Grantee Meeting, September 14,

Prime Therapeutics LLC (Prime) and RxRevu , the nation’s leading prescription price transparency company, are teaming up to offer Real Time Benefit Check, aka Real-Time Prescription Benefit, aiming to improve members’ health while